{"id":56894,"date":"2026-06-02T14:59:09","date_gmt":"2026-06-02T14:59:09","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=56894"},"modified":"2026-06-02T15:48:23","modified_gmt":"2026-06-02T15:48:23","slug":"gsk-stockmann-advises-deutsche-beteiligungs-ag-on-investment-in-tnl-group","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/gsk-stockmann-advises-deutsche-beteiligungs-ag-on-investment-in-tnl-group\/","title":{"rendered":"GSK Stockmann advises Deutsche Beteiligungs AG on investment in TNL Group"},"content":{"rendered":"<p><strong>GSK\u00a0Stockmann advised Deutsche Beteiligungs AG (DBAG) on its acquisition of a majority stake in the TNL Group (TNL). TNL specialises in environmental planning and permitting consulting in the field of energy and transport infrastructure. DBAG ECF IV, a fund advised by DBAG, is acquiring a majority stake in TNL as part of a management buy-out. The transaction is subject to regulatory approvals.<\/strong><\/p>\n<p><!--more--><\/p>\n<p>A multidisciplinary GSK\u00a0Stockmann team led by Berlin-based partner Robert Kornd\u00f6rfer provided comprehensive advice on the transaction. The firm\u2019s in-depth knowledge of the energy industry, coupled with its many years of experience in the German SME sector, played a crucial role. For DBAG, this investment represents a significant expansion of its portfolio, adding another resilient business model that is highly relevant to the current political issues of green energy and transport transition. A key consideration in structuring the transaction was the possibility of TNL management reinvesting in the company. Both parties have agreed not to disclose the purchase price.<\/p>\n<p>TNL is a specialised provider of environmental planning, permitting and construction services for complex infrastructure projects. Founded in 1994 by Frank Bernshausen, the company started out as a surveyors\u2019 office. Today, it supports challenging construction projects, such as wind and solar parks, high-voltage and extra-high-voltage power lines and transport infrastructure projects. TNL employs around 250 people across four sites and generated total revenue of approximately EUR 30 million in 2025. As the new majority shareholder, DBAG intends to systematically build on the company\u2019s recent growth trajectory.<\/p>\n<p><u>DBAG Deal Team<\/u>: Christoph Gro\u00dfek\u00e4mper, Alexander Jeanneaux, Maura Kolbe, Marisa Menzel<br \/>\n<u>DBAG Legal<\/u>: Carolin Keferstein<\/p>\n<p><u> <img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-56896\" src=\"https:\/\/www.legal500.com\/developments\/wp-content\/uploads\/sites\/19\/2026\/06\/Team-GSK-Stockmann-DBAG-300x175.jpg\" alt=\"\" width=\"300\" height=\"175\" srcset=\"https:\/\/my.legal500.com\/developments\/wp-content\/uploads\/sites\/19\/2026\/06\/Team-GSK-Stockmann-DBAG-300x175.jpg 300w, https:\/\/my.legal500.com\/developments\/wp-content\/uploads\/sites\/19\/2026\/06\/Team-GSK-Stockmann-DBAG-768x449.jpg 768w, https:\/\/my.legal500.com\/developments\/wp-content\/uploads\/sites\/19\/2026\/06\/Team-GSK-Stockmann-DBAG.jpg 1024w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/u><\/p>\n<p><u>\u00a0<\/u><\/p>\n<p><u>Advisers of Deutsche Beteiligungs AG at GSK\u00a0Stockmann:<\/u><\/p>\n<p>Robert Kornd\u00f6rfer (lead), Daniel Fehling und Clara L\u00f3pez Hernando (both PE\/M&amp;A), Dr\u00a0Oda Wedemeyer and Nicolas St\u00f6rmann (both Construction &amp; Architectural Law), Nicole Deparade and Katrin Zukovskaja (both Employment\/ Compensation &amp; Benefits), Dominik Berka (Tax), Maik Sch\u00e4ffer (M&amp;A\/Corporate), Dr\u00a0Martin Hossenfelder and Dr\u00a0Maximilian Schnebbe (both IP\/Data Protection), Dr\u00a0Jenny Mehlitz and Fabian Schiefner (both Public Procurement), Caglayan Birkan and Ensar Bing\u00f6l (both Tenancy Law).<\/p>\n<p>&nbsp;<\/p>\n<p>###<\/p>\n<table>\n<tbody>\n<tr>\n<td width=\"293\"><strong>Contact:<\/strong><\/p>\n<p>GSK STOCKMANN<\/p>\n<p>Robert Kornd\u00f6rfer<\/p>\n<p>Anton-Wilhelm-Amo-Str. 42<\/p>\n<p>10117 Berlin<\/p>\n<p>T +49 30 203907\u200a-\u200a93<\/p>\n<p>F +49 30 203907-44<\/p>\n<p><a href=\"mailto:robert.korndoerfer@gsk.de\">robert.korndoerfer@gsk.de<\/a><\/td>\n<td width=\"217\"><strong>Press contact:<\/strong><\/p>\n<p>GSK STOCKMANN<\/p>\n<p>Christina Holl<\/p>\n<p>Karl-Scharnagl-Ring 8<\/p>\n<p>80539 Munich<\/p>\n<p>T +49 89 288174-275<\/p>\n<p>F +49 89 288 174-44<\/p>\n<p><a href=\"mailto:presse@gsk.de\">presse@gsk.de<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt\/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind: <strong>Your perspective.<\/strong><\/p>\n<p>More about us: www.gsk.de\/en<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-56894","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/56894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=56894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}